All MiMedx Group articles

  • /web/img/field/image/sec_0.jpg

    SEC charges MiMedx Group with accounting fraud


    Biotech company MiMedx Group and three of its former top executives have been charged with defrauding investors. In response, MiMedx reshuffled its management team, including the appointment of a new general counsel and secretary.

  • Blog post

    MiMedx makes leadership changes amid accounting probe


    MiMedx Group, a developer and marketer of regenerative and therapeutic biologics, has appointed Mark Graves as chief compliance officer. The company also is conducting a formal search to fill the newly established positions of chief accounting officer and internal auditor, amid an ongoing investigation into accounting violations.